Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 30.00 |
P127306
Closed
Zeina El Khoury
Lebanese Republic
February 28, 2012
(as of board presentation)
October 31, 2012
February 3, 2015
US$ 30.00 million
Kafalat
2013
US$ 30.00 million
F
N/A
June 30, 2024
No
BANK APPROVED
November 14, 2023
Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 30.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 30.00 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 30.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 30.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Feb 15, 2019 | IBRD-82020 | Loan Repay | 587,108.75 |
Mar 30, 2018 | IBRD-82020 | Loan Disb | 52,473.42 |
Mar 28, 2018 | IBRD-82020 | Loan Disb | 578,600.00 |
Feb 15, 2018 | IBRD-82020 | Int Charges | 409.31 |
Feb 15, 2018 | IBRD-82020 | Int Charges | 91,605.94 |
Aug 3, 2016 | IBRD-82020 | Loan Disb | 404,598.50 |
Jul 11, 2017 | IBRD-82020 | Loan Disb | 236,525.00 |
Feb 21, 2017 | IBRD-82020 | Loan Disb | 1,453,402.40 |
Feb 21, 2017 | IBRD-82020 | Loan Disb | 368,103.00 |
Feb 15, 2017 | IBRD-82020 | Int Charges | 165.89 |
Feb 15, 2017 | IBRD-82020 | Int Charges | 45,490.32 |
Nov 6, 2017 | IBRD-82020 | Loan Disb | 582,335.00 |
Oct 10, 2017 | IBRD-82020 | Loan Disb | 2,124,500.00 |
Aug 15, 2017 | IBRD-82020 | Int Charges | 65,234.73 |
Feb 15, 2016 | IBRD-82020 | Int Charges | 22,754.46 |
Aug 15, 2016 | IBRD-82020 | Int Charges | 31,859.79 |
Feb 3, 2015 | IBRD-82020 | Loan Disb | 75,000.00 |
Feb 3, 2015 | IBRD-82020 | Fee Charges | 75,000.00 |
Mar 31, 2015 | IBRD-82020 | Loan Disb | 5,000,000.00 |
Aug 15, 2015 | IBRD-82020 | Int Charges | 15.75 |
Aug 15, 2015 | IBRD-82020 | Int Charges | 13,777.45 |
Sep 8, 2015 | IBRD-82020 | Loan Disb | 48,525.00 |
Aug 27, 2024 | IBRD-82020 | Int Charges | 2,715.66 |
Aug 27, 2024 | IBRD-82020 | Int Charges | 214.33 |
Aug 27, 2024 | IBRD-82020 | Int Charges | 430,825.03 |
Aug 27, 2024 | IBRD-82020 | Loan Repay | 1,234,015.90 |
Feb 16, 2024 | IBRD-82020 | Int Charges | 1,476.17 |
Feb 16, 2024 | IBRD-82020 | Int Charges | 468,471.90 |
Feb 16, 2024 | IBRD-82020 | Loan Repay | 1,234,015.90 |
Feb 16, 2024 | IBRD-82020 | Int Charges | 4,430.13 |
Oct 31, 2012 | IBRD-82020 | Loan Commitment | 30,000,000.00 |
Mar 1, 2023 | IBRD-82020 | Int Charges | 26,675.17 |
Mar 1, 2023 | IBRD-82020 | Int Charges | 2,207.70 |
Mar 1, 2023 | IBRD-82020 | Int Charges | 339,717.03 |
Mar 1, 2023 | IBRD-82020 | Loan Repay | 1,103,061.40 |
Aug 22, 2023 | IBRD-82020 | Int Charges | 16,164.12 |
Aug 22, 2023 | IBRD-82020 | Int Charges | 2,167.72 |
Aug 22, 2023 | IBRD-82020 | Int Charges | 408,459.06 |
Aug 22, 2023 | IBRD-82020 | Loan Repay | 1,234,015.90 |
Jun 8, 2023 | IBRD-82020 | Loan Disb | 1,698,502.00 |
Jan 24, 2019 | IBRD-82020 | Loan Disb | 941,522.00 |
Feb 15, 2019 | IBRD-82020 | Int Charges | 197,193.98 |
Sep 6, 2022 | IBRD-82020 | Int Charges | 97,422.66 |
Sep 6, 2022 | IBRD-82020 | Int Charges | 1,258.72 |
Sep 6, 2022 | IBRD-82020 | Loan Repay | 1,103,061.40 |
Sep 8, 2021 | IBRD-82020 | Int Charges | 68,724.25 |
Sep 8, 2021 | IBRD-82020 | Loan Repay | 1,103,061.40 |
Mar 31, 2022 | IBRD-82020 | Loan Repay | 1,103,061.40 |
Mar 31, 2022 | IBRD-82020 | Int Charges | 507.40 |
Mar 31, 2022 | IBRD-82020 | Int Charges | 62,145.06 |
Feb 15, 2021 | IBRD-82020 | Int Charges | 10,402.50 |
Feb 15, 2021 | IBRD-82020 | Int Charges | 85,126.50 |
Feb 15, 2021 | IBRD-82020 | Loan Repay | 1,103,061.40 |
Apr 8, 2020 | IBRD-82020 | Loan Disb | 757,160.00 |
Apr 8, 2020 | IBRD-82020 | Loan Disb | 373,263.00 |
Jun 19, 2020 | IBRD-82020 | Loan Disb | 3,000,000.00 |
Aug 15, 2020 | IBRD-82020 | Int Charges | 193,030.88 |
Aug 15, 2020 | IBRD-82020 | Loan Repay | 936,261.40 |
Nov 14, 2019 | IBRD-82020 | Loan Disb | 1,535,800.50 |
Aug 15, 2019 | IBRD-82020 | Int Charges | 3,707.11 |
Aug 15, 2019 | IBRD-82020 | Int Charges | 257,233.16 |
Aug 15, 2019 | IBRD-82020 | Loan Repay | 780,125.50 |
Oct 18, 2019 | IBRD-82020 | Loan Disb | 391,596.75 |
Feb 15, 2020 | IBRD-82020 | Int Charges | 213,992.98 |
Feb 15, 2020 | IBRD-82020 | Loan Repay | 876,688.06 |
Feb 19, 2019 | IBRD-82020 | Loan Disb | 684,500.00 |
May 24, 2019 | IBRD-82020 | Loan Disb | 526,207.00 |
Apr 17, 2019 | IBRD-82020 | Loan Disb | 806,945.00 |
May 22, 2018 | IBRD-82020 | Loan Disb | 768,996.00 |
Jun 12, 2018 | IBRD-82020 | Loan Disb | 1,210,430.00 |
Aug 15, 2018 | IBRD-82020 | Int Charges | 146,587.60 |
Jan 24, 2019 | IBRD-82020 | Loan Disb | 1,087,298.50 |
Name | Review | Date |
---|---|---|
Financial Management | Moderately Satisfactory | 2023-11-27 |
Procurement | Satisfactory | 2023-11-27 |
Project Management | Satisfactory | 2023-11-27 |
Progress towards achievement of PDO | Satisfactory | 2023-11-27 |
Monitoring and Evaluation | Satisfactory | 2023-11-27 |
Overall Implementation Progress (IP) | Satisfactory | 2023-11-27 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: |
---|---|
Outcomes | |
Risk to Development Outcome | |
Bank Performance | |
Borrower Performance | |
Government Performance | |
Implementing Agency |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Total number of firms receiving equity financing leveraging investors and the iSME funding program | Value | 0.00 | 87.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
Percent of beneficiary firms reporting sales of new medical goods and services sales | Value | 0.00 | 0.00 | 0.00 |
Date | March 31, 2020 | November 8, 2023 | ||
Comment |
No. of beneficiary firms, women owned | Value | 0.00 | 10.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
Total amount of equity financing received (leveraged) leveraging investors and the iSME funding program | Value | 0.00 | 93341655.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
Number of new jobs created in beneficiary firms | Value | 0.00 | 1760.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
No. of new jobs created, of which % are filled by women | Value | 0.00 | 43.47 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Intermediate Result Indicator 1: No. of eligible firms applying for proof of concept grants | Value | 0.00 | 373.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
Intermediate Result Indicator 8: Percent of firms reporting that iSME funding contribute to jobs protection during the economic crisis and COVID-19 outbreak | Value | 0.00 | 0.00 | 0.00 |
Date | March 31, 2020 | November 8, 2023 | ||
Comment |
Intermediate Result Indicator 2: No. of firms receiving proof of concept grants | Value | 0.00 | 209.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
Project implementation is satisfactory | Value | Yes | Yes | |
Date | May 25, 2022 | November 8, 2023 | ||
Comment |
Intermediate Result Indicator 7: No. of firms receiving funding from the COVID19 financing facility | Value | 0.00 | 0.00 | 0.00 |
Date | March 31, 2020 | November 8, 2023 | ||
Comment |
Intermediate Result Indicator 3: Vol. of proof of concept grants | Value | 0.00 | 3000000.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
Intermediate Result Indicator 4: Vol. of equity investments mobilized by Grantees | Value | 0.00 | 29090000.00 | 0.00 |
Date | March 2, 2015 | November 8, 2023 | ||
Comment |
Intermediate Result Indicator 5: No. of firms successfully receiving equity | Value | 0.00 | 24.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |
Intermediate Result Indicator 6: Vol. of equity investments mobilized as co-investments in portfolio of companies | Value | 0.00 | 64251655.00 | 0.00 |
Date | February 4, 2015 | November 8, 2023 | ||
Comment |